Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features

Journal of Urology

Volumn 195, Issue 4, 2016, Pages 852-858

  Ito, Timothy ^a   Pei, Jianming ^a   Dulaimi, Essel ^a   Menges, Craig ^a   Abbosh, Philip H ^a   Smaldone, Marc C ^a   Chen, David Y T ^a   Greenberg, Richard E ^a   Kutikov, Alexander ^a   Viterbo, Rosalia ^a   Uzzo, Robert G ^a   Testa, Joseph R ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

carcinoma, renal cell; chromosome aberrations; kidney; microarray analysis; polymorphism, single nucleotide

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CHROMOSOME 1; CHROMOSOME 15; CHROMOSOME 15Q; CHROMOSOME 18; CHROMOSOME 18P; CHROMOSOME 18Q; CHROMOSOME 22; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME 9Q; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; COPY NUMBER VARIATION; FOLLOW UP; GENOMICS; HUMAN; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; KIDNEY TUMOR; MORTALITY; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; RENAL CELL CARCINOMA; SURVIVAL ANALYSIS; TISSUE MICROARRAY;

CARCINOMA, RENAL CELL; DNA COPY NUMBER VARIATIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS;

EID: 84964402979     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.10.180     Document Type: Article

References (29)

1. Shuch, B., Bratslavsky, G., Linehan, W.M., et al. Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist, 17, 2012, 46.
2. Jones, T.D., Eble, J.N., Wang, M., et al. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation. Cancer, 104, 2005, 1195.
3. Pei, J., Feder, M.M., Al-Saleem, T., et al. Combined classical cytogenetics and microarray-based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinoma. Genes Chromosomes Cancer, 49, 2010, 610.
4. Roberts, J.L., Buckley, R.H., Luo, B., et al. CD45-deficient severe combined immunodeficiency caused by uniparental disomy. Proc Natl Acad Sci U S A, 109, 2012, 10456.
5. Pei, J., Jhanwar, S.C., Testa, J.R., Chromothripsis in a case of tp53-deficient chronic lymphocytic leukemia. Leuk Res Rep, 1, 2012, 4.
6. Molina, A.M., Tickoo, S.K., Ishill, N., et al. Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease. Am J Clin Oncol, 34, 2011, 454.
7. Golshayan, A.R., George, S., Heng, D.Y., et al. Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. J Clin Oncol, 27, 2009, 235.
8. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499, 2013, 43.
9. Durinck, S., Stawiski, E.W., Pavia-Jimenez, A., et al. Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. Nature, 47, 2015, 13.
10. Kovac, M., Navas, C., Horswell, S., et al. Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution. Nat Commun, 6, 2015, 6336.
11. Davis, C.F., Ricketts, C.J., Wang, M., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 26, 2014, 319.
12. Dal Cin, P., Sciot, R., Van Poppel, H., et al. Chromosome changes in sarcomatoid renal carcinomas are different from those in renal cell carcinomas. Cancer Genet Cytogenet, 134, 2002, 38.
13. Brunelli, M., Gobbo, S., Cossu-Rocca, P., et al. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod Pathol, 20, 2007, 303.
14. Jiang, F., Moch, H., Richter, J., et al. Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal carcinomas with sarcomatoid transformation. J Pathol, 185, 1998, 382.
15. Moore, L.E., Jaeger, E., Nickerson, M.L., et al. Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation. Oncogenesis, 1, 2012, e14.
16. Dagher, J., Dugay, F., Verhoest, G., et al. Histologic prognostic factors associated with chromosomal imbalances in a contemporary series of 89 clear cell renal cell carcinomas. Hum Pathol, 44, 2013, 2106.
17. Chen, M., Ye, Y., Yang, H., et al. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. Int J Cancer, 125, 2009, 2342.
18. Arai, E., Ushijima, S., Tsuda, H., et al. Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcome. Clin Cancer Res, 14, 2008, 5531.
19. Gronwald, J., Storkel, S., Holtgreve-Grez, H., et al. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Cancer Res, 57, 1997, 481.
20. Klatte, T., Kroeger, N., Rampersaud, E.N., et al. Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma. Cancer, 118, 2012, 5777.
21. Li, B., Qiu, B., Lee, D.S., et al. Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature, 513, 2014, 251.
22. Bernardi, R., Guernah, I., Jin, D., et al. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. Nature, 442, 2006, 779.
23. Lin, Y.C., Lu, L.T., Chen, H.Y., et al. SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling. Cancer Res, 74, 2014, 6935.
24. Kim, K.H., Roberts, C.W., Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth. Cancer Genet, 207, 2014, 365.
25. Roe, J.S., Kim, H.R., Hwang, I.Y., et al. Phosphorylation of von Hippel-Lindau protein by checkpoint kinase 2 regulates p53 transactivation. Cell Cycle, 10, 2011, 3920.
26. Conant, J.L., Peng, Z., Evans, M.F., et al. Sarcomatoid renal cell carcinoma is an example of epithelial-mesenchymal transition. J Clin Pathol, 64, 2011, 1088.
27. Sung, C.O., Choi, H., Lee, K.W., et al. Sarcomatoid carcinoma represents a complete phenotype with various pathways of epithelial mesenchymal transition. J Clin Pathol, 66, 2013, 601.
28. Gnemmi, V., Bouillez, A., Gaudelot, K., et al. MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/beta-catenin pathway and interaction with SNAIL promoter. Cancer Lett, 346, 2014, 225.
29. Tang, S.W., Chang, W.H., Su, Y.C., et al. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells. Cancer Lett, 273, 2009, 35.